Fortrea Holdings (FTRE) EBITDA Margin (2022 - 2026)
Fortrea Holdings (FTRE) reported EBITDA Margin of 0.53% for Q1 2026, up 7932.0% on a YoY basis from 0.01% in Q1 2025, and up 74.06% quarter-over-quarter from 2.06% in Q4 2025.
Fortrea Holdings (FTRE) EBITDA Margin (2022 - 2026) Analysis & Trends
Fortrea Holdings has reported EBITDA Margin for 5 years, with the latest figure at 0.53% in Q1 2026.
- For the quarter ending Q1 2026, EBITDA Margin rose 7932.0% year-over-year to 0.53%; the trailing twelve-month figure through Mar 2026 stood at 13.14% (up 1086.0% YoY), and the FY2025 full-year result was 31.32%, down 2622.0% from the prior year.
- EBITDA Margin for Q1 2026 stood at 0.53%, up from 2.06% in the prior quarter.
- The five-year high for EBITDA Margin was 9.04% in Q3 2022, with the low at 79.86% in Q1 2025.
- Historically, EBITDA Margin has averaged 8.05% across 5 years, with a median of 1.64% in 2025.
- Annual changes were most pronounced in 2025 — EBITDA Margin tumbled 7421 bps — and 2026, when it soared 7932 bps.
- Fortrea Holdings' EBITDA Margin stood at 2.85% in 2022, then tumbled by 219 bps to 3.38% in 2023, then sank by 136 bps to 7.98% in 2024, then jumped by 74 bps to 2.06% in 2025, then surged by 74 bps to 0.53% in 2026.
- The last three EBITDA Margin figures came in at 0.53% (Q1 2026), 2.06% (Q4 2025), and 1.23% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -6.43% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 38.10% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Fortrea Holdings | 1.43 Bn | 1.28 Bn | 123.60 Mn | -0.53% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.53% |
| Dec 31, 2025 | -2.06% |
| Sep 30, 2025 | -1.23% |
| Jun 30, 2025 | -46.50% |
| Mar 31, 2025 | -79.86% |
| Dec 31, 2024 | -7.98% |
| Sep 30, 2024 | -2.67% |
| Jun 30, 2024 | -7.68% |
| Mar 31, 2024 | -5.65% |
| Dec 31, 2023 | -3.38% |
| Sep 30, 2023 | 1.44% |
| Jun 30, 2023 | 4.36% |
| Mar 31, 2023 | 2.03% |
| Dec 31, 2022 | 2.85% |
| Sep 30, 2022 | 9.04% |
| Jun 30, 2022 | 8.98% |